cgp 12177 has been researched along with Airflow Obstruction, Chronic in 1 studies
CGP 12177 : A benzimidazole that is benzimidazol-2-one substituted at position 4 by a 3-(tert-butylamino)-2-hydroxypropoxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This pharmacological profile combined with clinical data is consistent with once a day dosing of vilanterol in the treatment of both asthma and chronic obstructive pulmonary disease (COPD)." | 1.39 | In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action. ( Barrett, VJ; Emmons, AJ; Ford, AJ; Knowles, RG; Morrison, VS; Slack, RJ; Sturton, RG, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Slack, RJ | 1 |
| Barrett, VJ | 1 |
| Morrison, VS | 1 |
| Sturton, RG | 1 |
| Emmons, AJ | 1 |
| Ford, AJ | 1 |
| Knowles, RG | 1 |
1 other study available for cgp 12177 and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Albuterol; Animals; Ben | 2013 |